Seeking calm on the cancer ward
When people choose to have their leukemia treated aggressively, it's a big commitment, more so than for almost any other cancer. With this therapy — three days of the drug daunorubicin, which comes in a reddish color so distinctive that one of my patients, a former chemist, used it in his professional life as a dye for plastics, and seven days of the drug cytarabine, which is infused continuously over 168 hours — we offer them the chance to be cured of a disease moving like wildfire with a stiff breeze behind it at the height of drought.
- Providers Lag as Consumers Set Agenda
- Look Beyond Nurse-Patient Ratios
- Reform Puts Vise Grips on Physicians
- Esther Dyson Launches Population Health Challenge
- Crisis Spurs Healthcare Payment Reform in Arkansas
- Hospital Groups Back NQF Report on Patient Sociodemographics
- ICD-10 Delay Alters Provider, Vendor Prep
- NPP Demand Rising Under Value-Based Care Models
- Medicare Opt-Out a Viable Physician Strategy
- Reduce Readmissions by Activating Patients to Do 'Self-Care'